<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36369208</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-1770</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Best practice &amp; research. Clinical rheumatology</Title><ISOAbbreviation>Best Pract Res Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications.</ArticleTitle><Pagination><StartPage>101794</StartPage><MedlinePgn>101794</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.berh.2022.101794</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1521-6942(22)00053-5</ELocationID><Abstract><AbstractText>As of this writing, it is estimated that there have been nearly 600 million cases of coronavirus disease 2019 (COVID-19) around the world with over six million deaths. While shocking, these figures do not fully illustrate the morbidity associated with this disease. It is also estimated that between 10% and 30% of those who survive COVID-19 develop persistent symptoms after the acute infection has passed. These individuals, who most often experienced initial infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) considered mild to moderate in severity, often display a broad array of symptoms. Collectively, this disorder or syndrome is now referred to as Long COVID (among other designations), and it represents a national/international health crisis. The most frequently reported symptoms associated with Long COVID include chronic fatigue with post exertional features, neurocognitive dysfunction, breathlessness, and somatic pain. Long COVID can range in severity from mild to severely debilitating, with resultant loss of quality of life and productivity. For now, there are many unanswered questions surrounding Long COVID: how can it be best defined, what is needed for accurate diagnosis, what is causing it, and how should it be best managed. How rheumatologists will engage in the Long COVID pandemic is another question; at the minimum, we will be called upon to evaluate and manage our own patients with immune-mediated inflammatory diseases who have developed it. This review focuses on addressing the disease essentials, providing both declarative and procedural knowledge to prepare rheumatologists for how to address Long COVID: understanding its origins, its current case definitions, epidemiology, pathobiology and clinical manifestations. Finally, it will provide an outline on how to clinically approach patients with possible Long COVID and initiate treatment and/or guide them on how to best manage it.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Calabrese</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirchner</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabrese</LastName><ForeName>Leonard H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, USA. Electronic address: calabrl@ccf.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Best Pract Res Clin Rheumatol</MedlineTA><NlmUniqueID>101121149</NlmUniqueID><ISSNLinking>1521-6942</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012219" MajorTopicYN="Y">Rheumatology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword></KeywordList><CoiStatement>Declaration of competing interest LHC: AstraZeneca. CC: AstraZeneca.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>23</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36369208</ArticleId><ArticleId IdType="pmc">PMC9641578</ArticleId><ArticleId IdType="doi">10.1016/j.berh.2022.101794</ArticleId><ArticleId IdType="pii">S1521-6942(22)00053-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ledford H. How common is long COVID? Why studies give different answers. Nature. 2022;606(7916):852&#x2013;853. doi: 10.1038/d41586-022-01702-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-01702-2</ArticleId><ArticleId IdType="pubmed">35725828</ArticleId></ArticleIdList></Reference><Reference><Citation>Hope A.A., Evering T.H. Postacute sequelae of severe acute respiratory syndrome Coronavirus 2 infection. Infect Dis Clin North Am. 2022;36(2):379&#x2013;395. doi: 10.1016/j.idc.2022.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2022.02.004</ArticleId><ArticleId IdType="pmc">PMC8843334</ArticleId><ArticleId IdType="pubmed">35636906</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S., Williams M.A. Confronting our next national health disaster &#x2014; long-haul covid. N&#xa0;Engl J Med. 2021;385(7):577&#x2013;579. doi: 10.1056/NEJMp2109285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2109285</ArticleId><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine R.L. Addressing the long-term effects of COVID-19. JAMA. Aug 3 2022 doi: 10.1001/jama.2022.14089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.14089</ArticleId><ArticleId IdType="pubmed">35921084</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deeks S.G. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 2022;43(4):268&#x2013;270. doi: 10.1016/j.it.2022.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal L.H. What is causing the 'long-hauler' phenomenon after COVID-19? Cleve Clin J Med. May 3 2021;88(5):273&#x2013;278. doi: 10.3949/ccjm.88a.21009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.88a.21009</ArticleId><ArticleId IdType="pubmed">33941601</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. May 2022;28(5):911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. Sep 2021;27(9):895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C.X., Wyller V.B.B., Moss-Morris R., et al. Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect Dis. Oct 2021;8(10):ofab440. doi: 10.1093/ofid/ofab440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L., Bested A.C., Bonilla H.F., et al. Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. 2021;96(11):2861&#x2013;2878. doi: 10.1016/j.mayocp.2021.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med. 2020;7 doi: 10.3389/fmed.2020.606824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman M. Chronic fatigue syndrome and long covid: moving beyond the controversy. BMJ. Jun 23 2021;373:n1559. doi: 10.1136/bmj.n1559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1559</ArticleId><ArticleId IdType="pubmed">34162532</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D.H., Roy D.J., Gu B.J., Hassett L.C., McCoy R.G. Postacute sequelae of severe acute respiratory syndrome Coronavirus 2 infection: a state-of-the-art review. JACC Basic Transl Sci. Sep-Oct 2021;6(9):796&#x2013;811. doi: 10.1016/j.jacbts.2021.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.07.002</ArticleId><ArticleId IdType="pmc">PMC8442719</ArticleId><ArticleId IdType="pubmed">34541421</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi N., Liu K., Kawakami D., et al. Post-intensive care syndrome and its new challenges in Coronavirus disease 2019 (COVID-19) pandemic: a review of recent advances and perspectives. J&#xa0;Clin Med. Aug 28 2021;10(17) doi: 10.3390/jcm10173870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10173870</ArticleId><ArticleId IdType="pmc">PMC8432235</ArticleId><ArticleId IdType="pubmed">34501316</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A&#xa0;clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. Apr 2022;22(4):e102&#x2013;e107. doi: 10.1016/s1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., olde Hartman T.C., Rosmalen J.G.M. Persistence of somatic symptoms after COVID-19 in The Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Wu Y., Xiong H., Mei B., You T. Persistence of symptoms after discharge of patients hospitalized due to COVID-19. Front Med. 2021;8 doi: 10.3389/fmed.2021.761314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.761314</ArticleId><ArticleId IdType="pmc">PMC8645792</ArticleId><ArticleId IdType="pubmed">34881263</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. Jun 28 2022;13(1):3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dowds J., O'Brien K., et al. Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. Jun 2021;18(6):997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11) doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., Levi R., Sarti R., et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. Jul 1 2022 doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis S.N., Durieux J.C., Mouchati C., Perez J.A., McComsey G.A. The protective effect of Coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of COVID-19: a multicenter study from a large national health research network. Open Forum Infect Dis. 2022;9(7):ofac228. doi: 10.1093/ofid/ofac228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. May 25 2022 doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbaraman N. US health agency will invest $1 billion to investigate &#x2018;long COVID&#x2019;. Nature. 2021;591(7850):356. doi: 10.1038/d41586-021-00586-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-00586-y</ArticleId><ArticleId IdType="pubmed">33664445</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota H.R., Nune A. Long COVID from rheumatology perspective - a narrative review. Clin Rheumatol. 2022;41(2):337&#x2013;348. doi: 10.1007/s10067-021-06001-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-06001-1</ArticleId><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Iorio M., Cook C.E., Vanni K.M.M., et al. DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: a prospective study. Semin Arthritis Rheum. Aug 2022;55 doi: 10.1016/j.semarthrit.2022.152025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2022.152025</ArticleId><ArticleId IdType="pmc">PMC9116968</ArticleId><ArticleId IdType="pubmed">35617780</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nature Immunol. 2022;23(2):194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. Apr 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Res Square. Mar 1 2021 doi: 10.21203/rs.3.rs-266574/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-266574/v1</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38 doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Bili&#x144;ska K., von Bartheld C. Why does the omicron variant largely spare olfactory function? Implications for the pathogenesis of anosmia in COVID-19. J&#xa0;Infect Dis. Apr 25 2022 doi: 10.1093/infdis/jiac113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac113</ArticleId><ArticleId IdType="pmc">PMC9129133</ArticleId><ArticleId IdType="pubmed">35467743</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Margalit I., Nehme M., et al. Patterns of long COVID symptoms: a multi-center cross sectional study. J&#xa0;Clin Med. 2022;(4):11. doi: 10.3390/jcm11040898.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11040898</ArticleId><ArticleId IdType="pmc">PMC8875229</ArticleId><ArticleId IdType="pubmed">35207171</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies K., Dures E., Ng W.F. Fatigue in inflammatory rheumatic diseases: current knowledge and areas for future research. Nat Rev Rheumatol. 2021;17(11):651&#x2013;664. doi: 10.1038/s41584-021-00692-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00692-1</ArticleId><ArticleId IdType="pubmed">34599320</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz P. Fatigue in rheumatoid arthritis. Curr Rheumatol Rep. 2017;19(5):25. doi: 10.1007/s11926-017-0649-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-017-0649-5</ArticleId><ArticleId IdType="pubmed">28386762</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos-Reed S.N., Weatherald J., Wrightson J.G. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys Ther. Apr 1 2022;(4):102. doi: 10.1093/ptj/pzac005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-A systemic review and comparison of clinical presentation and symptomatology. Medicina. Apr 26 2021;57(5) doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L., Tosto-Mancuso J., Wood J., et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil. 1 2022;101(1):48&#x2013;52. doi: 10.1097/phm.0000000000001910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/phm.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Yang D., Lewis A., et al. A&#xa0;prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J&#xa0;Neurol Sci. Jul 15 2021;426 doi: 10.1016/j.jns.2021.117486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117486</ArticleId><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Simon N.M. Bridging knowledge gaps in the diagnosis and management of neuropsychiatric sequelae of COVID-19. JAMA Psychiatr. Jun 29 2022 doi: 10.1001/jamapsychiatry.2022.1616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.1616</ArticleId><ArticleId IdType="pubmed">35767287</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Shibata K., Hellyer P.J., et al. Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Commun. 2022;4(1):fcab295. doi: 10.1093/braincomms/fcab295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab295</ArticleId><ArticleId IdType="pmc">PMC8807287</ArticleId><ArticleId IdType="pubmed">35128398</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan K., Miller A.K., Reiter K., Bonner-Jackson A. Neurocognitive profiles in patients with persisting cognitive symptoms associated with COVID-19. Arch Clin Neuropsychol. May 16 2022;37(4):729&#x2013;737. doi: 10.1093/arclin/acac004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acac004</ArticleId><ArticleId IdType="pmc">PMC8903427</ArticleId><ArticleId IdType="pubmed">35136912</ArticleId></ArticleIdList></Reference><Reference><Citation>Neculicioiu V.S., Colosi I.A., Costache C., Sevastre-Berghian A., Clichici S. Time to sleep?-A review of the impact of the COVID-19 pandemic on sleep and mental health. Int J Environ Res Public Health. Mar 16 2022;19(6) doi: 10.3390/ijerph19063497.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19063497</ArticleId><ArticleId IdType="pmc">PMC8954484</ArticleId><ArticleId IdType="pubmed">35329184</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoudi H., Saffari M., Movahedi M., et al. A&#xa0;mediating role for mental health in associations between COVID-19-related self-stigma, PTSD, quality of life, and insomnia among patients recovered from COVID-19. Brain Behav. May 2021;11(5) doi: 10.1002/brb3.2138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2138</ArticleId><ArticleId IdType="pmc">PMC8119851</ArticleId><ArticleId IdType="pubmed">33811451</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoja O., Silva Passadouro B., Mulvey M., et al. Clinical characteristics and mechanisms of musculoskeletal pain in long COVID. J&#xa0;Pain Res. 2022;15:1729&#x2013;1748. doi: 10.2147/jpr.S365026.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jpr.S365026</ArticleId><ArticleId IdType="pmc">PMC9212788</ArticleId><ArticleId IdType="pubmed">35747600</ArticleId></ArticleIdList></Reference><Reference><Citation>Clauw D.J., H&#xe4;user W., Cohen S.P., Fitzcharles M.A. Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. Aug 2020;161(8):1694&#x2013;1697. doi: 10.1097/j.pain.0000000000001950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001950</ArticleId><ArticleId IdType="pmc">PMC7302093</ArticleId><ArticleId IdType="pubmed">32701829</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. Mar 24 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudman L., De Smedt A., Noppen M., Moens M. Is central sensitisation the missing link of persisting symptoms after COVID-19 infection? J&#xa0;Clin Med. 2021;28(23):10. doi: 10.3390/jcm10235594.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10235594</ArticleId><ArticleId IdType="pmc">PMC8658135</ArticleId><ArticleId IdType="pubmed">34884296</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F., Ciaffi J., Mancarella L., et al. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. Aug 2021;7(3) doi: 10.1136/rmdopen-2021-001735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2021-001735</ArticleId><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazaridou A., Paschali M., Vilsmark E.S., Wilkins T., Napadow V., Edwards R. The impact of COVID-19 pandemic on mental and physical wellbeing in women with fibromyalgia: a longitudinal mixed-methods study. BMC Women Health. Jun 30 2022;22(1):267. doi: 10.1186/s12905-022-01840-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12905-022-01840-9</ArticleId><ArticleId IdType="pmc">PMC9245870</ArticleId><ArticleId IdType="pubmed">35773702</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera J., Rodr&#xed;guez T., Pallar&#xe9;s M., et al. Prevalence of post-COVID-19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseases. BMC Muscoskel Disord. May 19 2022;23(1):471. doi: 10.1186/s12891-022-05436-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-022-05436-0</ArticleId><ArticleId IdType="pmc">PMC9117853</ArticleId><ArticleId IdType="pubmed">35590317</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey Q., Sheikh A., Daines L., Vasileiou E. Symptoms and signs of long COVID: a rapid review and meta-analysis. J&#xa0;Glob Health. May 21 2022;12 doi: 10.7189/jogh.12.05014.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05014</ArticleId><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="pubmed">35596571</ArticleId></ArticleIdList></Reference><Reference><Citation>Chippa V., Aleem A., Anjum F. StatPearls Publishing LLC.; 2022. Post Acute Coronavirus (COVID-19) Syndrome. StatPearls. StatPearls Publishing Copyright &#xa9; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">34033370</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston C.K., &#x15a;wi&#x105;tkiewicz I., Taub P.R. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. Jul 16 2022 doi: 10.1016/j.hrthm.2022.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType="pmc">PMC9287587</ArticleId><ArticleId IdType="pubmed">35853576</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaghan A., Jennings G., Xue F., Byrne L., Duggan E., Romero-Ortuno R. Orthostatic intolerance in adults reporting long COVID symptoms was not associated with postural orthostatic tachycardia syndrome. Front Physiol. 2022;13 doi: 10.3389/fphys.2022.833650.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.833650</ArticleId><ArticleId IdType="pmc">PMC8931464</ArticleId><ArticleId IdType="pubmed">35309052</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P., Mukerji S.S., Alabsi H.S., et al. Multisystem involvement in post-acute sequelae of Coronavirus disease 19. Ann Neurol. 2022;91(3):367&#x2013;379. doi: 10.1002/ana.26286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26286</ArticleId><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal S.M., Landers D.B., Hollenberg S.M., et al. Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J&#xa0;Am Coll Cardiol. Jun 14 2022;79(23):2325&#x2013;2330. doi: 10.1016/j.jacc.2022.03.357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.03.357</ArticleId><ArticleId IdType="pmc">PMC8976261</ArticleId><ArticleId IdType="pubmed">35381331</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID-19. Science (New York, NY) 11 2022;375(6585):1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome Coronavirus 2 infection. J&#xa0;Infect Dis. Dec 1 2021;224(11):1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J.S., Caricchio R., Casanova J.L., et al. The intersection of COVID-19 and autoimmunity. J&#xa0;Clin Invest. Dec 15 2021;(24):131. doi: 10.1172/jci154886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci154886</ArticleId><ArticleId IdType="pmc">PMC8670833</ArticleId><ArticleId IdType="pubmed">34710063</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deveau T.-M., Munter S.E., et al. Impact of pre-existing chronic viral infection and reactivation on the development of long COVID. medRxiv. 2022;2022 doi: 10.1101/2022.06.21.22276660. 06.21.22276660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.21.22276660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao J., Frankland P.W. COVID fog demystified. Cell. Jul 7 2022;185(14):2391&#x2013;2393. doi: 10.1016/j.cell.2022.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.020</ArticleId><ArticleId IdType="pmc">PMC9197953</ArticleId><ArticleId IdType="pubmed">35768007</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deeks S.G., Mustapic M., et al. SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann Neurol. 2022;91(6):772&#x2013;781. doi: 10.1002/ana.26350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo J., Weintraub M.I., Munoz R., et al. Long COVID and the autonomic nervous system: the journey from dysautonomia to therapeutic neuro-modulation through the retrospective analysis of 152 patients. NeuroSci. 2022;3(2):300&#x2013;310.</Citation></Reference><Reference><Citation>Bisaccia G., Ricci F., Recce V., et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know? J&#xa0;Cardiovasc Dev Dis. 2021;15(11):8. doi: 10.3390/jcdd8110156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd8110156</ArticleId><ArticleId IdType="pmc">PMC8621226</ArticleId><ArticleId IdType="pubmed">34821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Margalit I., Yelin D., Sagi M., et al. Risk factors and multidimensional assessment of long COVID fatigue: a nested case-control study. Clin Infect Dis. Apr 11 2022 doi: 10.1093/cid/ciac283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac283</ArticleId><ArticleId IdType="pmc">PMC9383780</ArticleId><ArticleId IdType="pubmed">35403679</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Cancela-Cilleruelo I., Moro-L&#xf3;pez-Menchero P., Rodr&#xed;guez-Jim&#xe9;nez J., Pellicer-Valero O.J. Trajectory curves of post-COVID anxiety/depressive symptoms and sleep quality in previously hospitalized COVID-19 survivors: the LONG-COVID-EXP-CM multicenter study. Psychol Med. 2022;10:1&#x2013;2. doi: 10.1017/s003329172200006x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s003329172200006x</ArticleId><ArticleId IdType="pmc">PMC8770842</ArticleId><ArticleId IdType="pubmed">35000650</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Koralnik I.J., Liotta E.M. Therapeutic approaches to the neurologic manifestations of COVID-19. Neurotherapeutics. Jul 21 2022:1&#x2013;32. doi: 10.1007/s13311-022-01267-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-022-01267-y</ArticleId><ArticleId IdType="pmc">PMC9302225</ArticleId><ArticleId IdType="pubmed">35861926</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. May 2021;8(5):1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller M.C., Liang C.J., Marques A.R., et al. A&#xa0;longitudinal study of COVID-19 sequelae and immunity: baseline findings. Ann Intern Med. 2022;175(7):969&#x2013;979. doi: 10.7326/m21-4905.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m21-4905</ArticleId><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Casals M., Brito-Zer&#xf3;n P., Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol. 2021;17(6):315&#x2013;332. doi: 10.1038/s41584-021-00608-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00608-z</ArticleId><ArticleId IdType="pmc">PMC8072739</ArticleId><ArticleId IdType="pubmed">33903743</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-index.html</Citation></Reference><Reference><Citation>Robbins R., Helmer D., Monahan P., et al. Management of chronic multisymptom illness: synopsis of the 2021 US department of Veterans affairs and US department of defense clinical practice guideline. Mayo Clin Proc. May 2022;97(5):991&#x2013;1002. doi: 10.1016/j.mayocp.2022.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2022.01.031</ArticleId><ArticleId IdType="pubmed">35410746</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehar S., Boushra M., Ntiamoah P., Biehl M. Post-acute sequelae of SARS-CoV-2 infection: caring for the &#x2018;long-haulers&#x2019;. Cleve Clin J Med. May 3 2021;88(5):267&#x2013;272. doi: 10.3949/ccjm.88a.21010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.88a.21010</ArticleId><ArticleId IdType="pubmed">33941600</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera J.E., Niehaus W.N., Whiteson J., et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. PMR. 2021;13(9):1027&#x2013;1043. doi: 10.1002/pmrj.12684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12684</ArticleId><ArticleId IdType="pmc">PMC8441628</ArticleId><ArticleId IdType="pubmed">34346558</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Islam M., Conroy K., et al. COVID-19 symptoms over time: comparing long-haulers to ME/CFS. Fatigue. 2021;9(2):59&#x2013;68. doi: 10.1080/21641846.2021.1922140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2021.1922140</ArticleId><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Kelly J.D., Lu S., et al. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement. Open Forum Infect Dis. 2022;9(2):ofab640. doi: 10.1093/ofid/ofab640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab640</ArticleId><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese L., Colloca L. Long COVID-19 and the role of the patient-clinician interaction in symptom management. J&#xa0;Patient Exp. 2022;9 doi: 10.1177/23743735221077514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23743735221077514</ArticleId><ArticleId IdType="pmc">PMC8832111</ArticleId><ArticleId IdType="pubmed">35155749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Itskovich S., Catalogna M., Sasson E., et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep. Jul 12 2022;12(1) doi: 10.1038/s41598-022-15565-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15565-0</ArticleId><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Long-COVID treatments: why the world is still waiting. Nature. Aug 2022;608(7922):258&#x2013;260. doi: 10.1038/d41586-022-02140-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-02140-w</ArticleId><ArticleId IdType="pubmed">35945375</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Williams M.C., Campbell D.M., et al. SARS-CoV-2 booster vaccination for participants in &#x201c;HIV cure&#x201d;-related clinical trials. J&#xa0;Acquir Immune Defic Syndr. 1 2022;89(3):e30. doi: 10.1097/qai.0000000000002875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/qai.0000000000002875</ArticleId><ArticleId IdType="pmc">PMC8851852</ArticleId><ArticleId IdType="pubmed">35147584</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895. doi: 10.1016/j.cell.2022.01.014. e20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Anglin K., Durstenfeld M.S., et al. Effect of oral nirmatrelvir on long COVID symptoms: 4 cases and rationale for systematic studies. Pathog Immun. 2022;7(1):95&#x2013;103. doi: 10.20411/pai.v7i1.518.</Citation><ArticleIdList><ArticleId IdType="doi">10.20411/pai.v7i1.518</ArticleId><ArticleId IdType="pmc">PMC9254867</ArticleId><ArticleId IdType="pubmed">35800257</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaylis N.B., Ritter A., Kelly S.A., et al. Reduced cell surface levels of C-C chemokine receptor 5 and immunosuppression in long Coronavirus disease 2019 syndrome. Clin Infect Dis. Apr 22 2022 doi: 10.1093/cid/ciac226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac226</ArticleId><ArticleId IdType="pmc">PMC9383814</ArticleId><ArticleId IdType="pubmed">35452519</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>